T. Rowe Price Associates »

Catalyst Pharmaceutical Partners shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2024-09-30 $25M 1.2M 19.88
2024-06-30 $19M 1.2M 15.50
2024-03-31 $19M 1.2M 15.94
2023-12-31 $20M 1.2M 16.81
2023-09-30 $14M 1.2M 11.69
2023-06-30 $15M 1.1M 13.44
2023-03-31 $17M 1.0M 16.58
2022-12-31 $18M 951k 18.60

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Apple Comm Stk (AAPL)
Nvidia Corporation Comm Stk (NVDA)
Amazon Comm Stk (AMZN)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Alphabet Comm Stk (GOOGL)
Unitedhealth Group Comm Stk (UNH)
Alphabet Comm Stk (GOOG)
Visa Comm Stk (V)
Mastercard Incorporated Comm Stk (MA)
Netflix Comm Stk (NFLX)
Tesla Comm Stk (TSLA)
Intuitive Surgical Comm Stk (ISRG)
Thermo Fisher Scientific Comm Stk (TMO)

View all positions for T. Rowe Price Associates

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Vanguard Group
Deerfield Management Company
State Street Corporation
Dimensional Fund Advisors
Pacer Advisors
Geode Capital Management
Renaissance Technologies
First Trust Advisors
Royce & Associates
Goldman Sachs Group
Northern Trust
Robeco Investment Management
T. Rowe Price Associates
Charles Schwab Investment Management

View all funds holding Catalyst Pharmaceutical Partners